glutathione for aging Liposomal Glutathione: The Ultimate Anti-Aging Antioxidant Glutathione IV Therapy - Philip

Commercial Development: In August 2025, Jocasta Neuroscience raised $35 million in Series A funding to advance JN-0413, a proprietary -klotho formulation, through Phase 1 trials with IND submission planned for Q4 2026

J Infect Dis 116:523528

A major obstacle is the difficulty of selectively targeting disease-relevant astrocyte subpopulations in the absence of well-defined marker proteins and robust methodologies against spatially restricted areas in various states in the disease progression (Liddelow et al., 2017

Larger, more comprehensive trials are underway to establish definitive evidence and seek FDA approval for this indication

Clinical Update 1/23/2025 Dose For Your Liver

This represents a modulatory rather than direct agonist/antagonist profile that distinguishes it from conventional dopaminergic drugs